Inpatient prescribing trends and differences in drug acquisition costs of long-acting injectable subcutaneous risperidone versus paliperidone palmitate: A single-center medication use evaluation

Introduction Literature comparing differences in efficacy of inpatient initiation of long-acting paliperidone palmitate once monthly (PP1M) and subcutaneous risperidone long acting-injectable (SC-RLAI) is currently limited and inconclusive. Differences in drug costs may guide choice of the preferred...

Full beskrivning

Sparad:

Bibliografiska uppgifter
Huvudupphov:	Andrew Chantha Hean, PharmD, BCPS, BCPP, Cadence Wong, Jung Hoon Park, PharmD, BCPS, BCCCP, Craig Stevens, PharmD, BCPS, Casey Tiefenthaler, PharmD, BCPP
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	American Association of Psychiatric Pharmacists 2026-02-01
Serie:	Mental Health Clinician
Ämnen:	risperidone paliperidone long-acting injectable drug cost inpatient
Länkar:	https://theijpt.org/doi/pdf/10.9740/mhc.2026.02.007
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!

Inpatient prescribing trends and differences in drug acquisition costs of long-acting injectable subcutaneous risperidone versus paliperidone palmitate: A single-center medication use evaluation

Liknande verk